formule PCT+
▶ 2.5ml x 3 syringes in 1 box:
▶ Maximum PDRN content with no irritation
▶ HA + PDRN + Niacinamide contained
▶ OMPI glass syringe used: Premium glass syringe
▶ ISO22716, CPNP Certificated
formule HP+
▶ 2.5ml x 1 syringe in 1 box
▶ HA 10 mg/mL, PN 10 mg/mL
▶ OMPI glass syringe used: Premium glass syringe
▶ ISO22716, CPNP Certificated
formule P+
▶ 2.5ml x 1 syringe in 1 box
▶ PN 20 mg/mL
▶OMPI glass syringe used: Premium glass syringe
▶ ISO22716, CPNP Certificated
formule HiLo+
▶HW-HA 40mg + LW+HA 40mg (HA 80mg/2.5ml)
▶ 1 syringe(2.5ml)
▶ OMPI glass syringe used: Premium glass syringe
▶ ISO22716, CPNP Certificated
formule PHiLo+
▶PN + HA Collaboration
▶HW-HA 40mg + LW+HA 40mg (HA 80mg/2.5ml) with Polynucleotide
▶ 1 syringe(2.5ml)
▶ OMPI glass syringe used: Premium glass syringe
▶ ISO22716, CPNP Certificated
formule NAD+
▶ NAD x NMN Synergic Collaboration for Full Activation
▶ 3 syringes X 2.5 mL in 1 box. Eco-wise, Cost-wise
▶ OVS Glass syringe for safe and easy use
Under the vision of ‘Leading the future of global bio-beauty through AI-driven peptide innovation,’ ZOE BIO is a next-generation bio-beauty solution provider. The company specializes in skin boosters and innovative skincare solutions, leveraging its proprietary AI-based peptide development technology alongside the manufacturing of plant-based PDRN, exosomes, and natural fermented cosmetic ingredients.
Established in 2015 as a leading Korean aesthetics company based on biomaterial research, ZOE BIO is accelerating its R&D capabilities through its unique AI-based peptide development platform, "AI ZPT."
Based on its Seoul-based factory and R&D center, ZOE BIO offers a diverse range of aesthetic products utilizing high-functional ingredients such as Peptide, PN, HA, NAD+ and NMN, and can provide tailored formulation technology to address these needs.
Furthermore, ZOE BIO aims to expand and establish collaborations with global buyers in the US, CIS, Europe, and Latin America through OEM and ODM businesses. Through ongoing R&D, ZOE BIO plans to continuously evolve and diversify its product portfolio.